Order Article Reprints

Filippopoulou F, Habeos GI, Rinotas V, Sophocleous A, Sykiotis GP, Douni E, Chartoumpekis DV. Dexamethasone Administration in Mice Leads to Less Body Weight Gain over Time, Lower Serum Glucose, and Higher Insulin Levels Independently of NRF2. Antioxidants. 2022; 11(1):4. https://doi.org/10.3390/antiox11010004

Filippopoulou, Fotini, George I. Habeos, Vagelis Rinotas, Antonia Sophocleous, Gerasimos P. Sykiotis, Eleni Douni, and Dionysios V. Chartoumpekis. 2022. "Dexamethasone Administration in Mice Leads to Less Body Weight Gain over Time, Lower Serum Glucose, and Higher Insulin Levels Independently of NRF2" Antioxidants 11, no. 1: 4. https://doi.org/10.3390/antiox11010004

Filippopoulou, F., Habeos, G. I., Rinotas, V., Sophocleous, A., Sykiotis, G. P., Douni, E., & Chartoumpekis, D. V. (2022). Dexamethasone Administration in Mice Leads to Less Body Weight Gain over Time, Lower Serum Glucose, and Higher Insulin Levels Independently of NRF2. Antioxidants, 11(1), 4. https://doi.org/10.3390/antiox11010004